FIELD: medicine. SUBSTANCE: method involves applying panretinal argon laser coagulation treatment, parabulbary administering 5 mg of epithalamine in 0.5-% novocaine solution during 5-7 days after each argon laser coagulation treatment, each argon laser coagulation treatment being carried out not earlier than 2-5 days later after the last epithalamine application being done. EFFECT: prevented complications related to laser treatment. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2124337C1 |
| METHOD OF PROPHYLAXIS OF DIABETIC RETINOPATHY | 1996 |
|
RU2140235C1 |
| METHOD FOR TREATING PATIENTS FOR PRE- AND PROLIFERATIVE RETINOPATHY | 2005 |
|
RU2283647C1 |
| METHOD FOR TREATING VASCULAR DISEASES OF EYES | 1995 |
|
RU2123870C1 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 2004 |
|
RU2270025C1 |
| METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2140236C1 |
| CONTROLLED LASER COAGULATION METHOD FOR TREATING EYE RETINA DISEASES | 1996 |
|
RU2144342C1 |
| METHOD OF TREATING PERIPHERAL TRACTION RETINAL DETACHMENT IN DIABETIC RETINOPATHY | 2019 |
|
RU2739698C1 |
| SURGICAL METHOD FOR TREATING DIABETIC RETINOPATHY | 1996 |
|
RU2125428C1 |
| METHOD OF COMBINED TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY CENTRAL RETINAL RUPTURE WITH ACCOMPANYING RETINOSCHISIS AND TRACTION-RHEGMATOGENOUS RETINAL DETACHMENT | 2023 |
|
RU2816782C1 |
